Regulatory Information Disclaimer: Statements in this article regarding FDA actions, the 503B Bulks List, drug shortage status, and the federal regulatory framework for compounded GLP-1 medications reflect FDA published guidance current as of May 2026
[DOI] [PMC free article] [PubMed] [Google Scholar] 81.Kasina S.V.S.K., Baradhi K.M
After the start of GLP-1RA treatment, participants were deemed to have discontinued the drug if they did not receive a refill for 90 days after their prescription ended
Cell Metab 2022;34:123447.ArticlePubMed 63
The summary is provided in Tables 13
Common GLP-1 Injections and Their FDA-Approved Uses Here are several GLP-1 receptor agonists currently available as injections: These medications must be prescribed by a licensed provider following an evaluation of your medical history, weight-related conditions, and current medications